Physician profile
Haley E Russell
NPI 1982072278
$13,305.72
in general payments reported to CMS, 2019-2025
12 companies · $4,190 in 2025
The $4,190 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $2,373 · 2023: $738 · 2024: $5,728 · 2025: $4,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,532 · Food and Beverage: $5,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,532.43 |
| Food and Beverage | $5,124.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,142.52 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Pulseselect |
| Impulse Dynamics (USA) INC. | $1,515.95 | 2025 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $421.19 | 2022-2025 | Lifevest |
| Cvrx, INC. | $264.11 | 2021-2025 | Barostim Neo System |
| Atricure, INC. | $213.13 | 2024 | |
| Boston Scientific Corporation | $212.34 | 2022-2025 | Watchman Flx |
| Biosense Webster, INC. | $139.52 | 2024-2025 | Carto 3 |
| Lexicon Pharmaceuticals, INC. | $113.73 | 2024 | Inpefa |
| Abbott Laboratories | $106.77 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.45 | 2024 | |
| Novartis Pharmaceuticals Corporation | $71.65 | 2025 | |
| Elutia, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.